When COVID-19 set upon the U.S. in March, medtech executives had a month at most to tell Wall Street analysts how the pandemic had hit the industry’s largest companies. We heard about short-term hits in revenues, procedures and employee headcounts, but uncertainty clearly ruled the day. Over the past few weeks, medtech executives from several […]
Smith & Nephew
MedTech 100 roundup: Industry hits another mid-pandemic high
Despite a minor regression week-over-week, the medtech industry’s stocks hit another milestone as the COVID-19 rebound remains in progress. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.01 points at the end of last week (July 31). Overall, medtech stocks saw a -0.3% increase from the […]
Smith+Nephew launches total hip arthroplasty system
Smith+Nephew (NYSE:SNN) today said it launched its RI Hip Navigation system for total hip arthroplasty. The technology is designed to maximize accuracy and reproducibility to deliver patient-specific component alignment for surgeons when assessing individual total hip arthroplasty cases. RI Hip Navigation helps surgeons take control of a patient’s pelvic tilt, leg length and offset measurement. It […]
Smith+Nephew launches next-gen surgical robotics system
Competition continues to heat up in the robotic orthopedic surgery space, with Smith+Nephew (LON:SN) today announcing the launch of its next-gen Cori surgical system. Cleared by FDA and available for both total and unicompartmental knee arthroplasty, the handheld Cori robotics platform is meant to be faster than S+N’s previous Navio system. On top of Cori, […]
MedTech 100 roundup: Stocks tick back up to open July
After a solid start to July, the medtech industry continues to experience a stock market roller coaster amid the COVID-19 pandemic. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 84.25 points at the end of last week (July 3). That total represents a 2.9% increase from […]
Smith & Nephew expects 29% sales dip in Q2
Smith & Nephew (NYSE:SNN) said today it expects second-quarter revenues to dip by 29% due to the coronavirus pandemic, although results gradually improved as time went on. Sales were hardest hit in the company’s orthopedic reconstruction, sports medicine and ENT businesses due to the pandemic-related lockdown and pause in elective surgeries. The company’s advanced wound management […]
Smith & Nephew Regeneten bioinductive implant wins CE mark
Smith & Nephew (NYSE:SNN) announced today that its Regeneten bioinductive implant for rotator cuff procedures received CE Mark approval in Europe. Regeneten, a collagen-based implant, supports the body’s natural healing process by inducing the growth of new tendon-like tissue to biologically augment the existing tendon and disrupt disease progression. The implant, which is the size of […]
Smith & Nephew launches Tula ear tube system
Smith & Nephew (NYSE:SNN) announced today that it launched its Tula system for the placement of tympanostomy tubes (ear tubes). London-based Smith & Nephew’s Tula system is an in-office option that allows surgeons to place ear tubes in an awake child without the need for general anesthesia. Physicians using the Tula system numb the eardrum with […]
Smith & Nephew launches unicompartmental knee system
Smith & Nephew (NYSE:SNN) today announced the launch of its new Journey II Unicompartmental Knee System. The system is a highly personalized approach to partial knee arthroplasty through a modular, two tray configuration. It works by introducing a lateral specific tibia baseplate and an increased size range for femoral components and medial tibia baseplates to optimize […]
MedTech 100 roundup: Stocks open strong in May
Medtech stocks took a dip as April came to a close, but opened May with a strong week as the COVID-19 pandemic continues to affect the economy. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 83.98 points at the end of last week (May 8). That […]
Smith & Nephew’s Q1 revenues take a hit amid COVID-19 pandemic
Smith & Nephew (NYSE:SNN) shares slightly ticked up today on first-quarter results that were heavily impacted by the ongoing COVID-19 pandemic. The London-based orthopedics and wound care giant posted a sales decline of 5.7%, dropping from $1.2 billion in sales this time last year to $1.1 for the quarter ended March 28, 2020. In March, the […]